Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Ceramic Bone Filler Helps in Bone Grafting

By HospiMedica International staff writers
Posted on 23 Mar 2010
A grafting option based on a novel bone-void filler is designed to fill in gaps in the skeletal system of the extremities, spine, and pelvis.

The Integra Mozaik Moldable Morsels void filler combines a type I collagen matrix with a highly pure form of beta-tricalcium phosphate that provides enhanced composite grafting, optimized compression resistance, and a mineral source, all properties that are essential for bone healing. More...
The Mozaik thus helps guide the regeneration of new bone across critical defect sites in which it has been implanted, with new bone formation initiated in the matrix surface as the graft is placed in direct apposition to living host bone; subsequently, the matrix is continually resorbed and remodeled as new bone is formed. When used with bone marrow aspirate from the patient, the moldable morsels may replace the need to harvest bone from the patient's iliac crest, thus sparing the patient additional surgery and postoperative pain.

Mozaik Moldable Morsels are a product of Integra LifeSciences (Plainsboro, NJ, USA), and are available in four sizes. The proprietary Type I collagen technology is also used in several of Integra's other regenerative products, including the DuraGen Plus dural regeneration matrix, the neuraGen nerve guide, and the Integra dermal regeneration template.

"The introduction of Integra Mozaik Moldable Morsels marks another milestone in the continuing development of our collagen ceramic bone grafting platform, and provides surgeons with one of the most innovative options for bone grafting,” said Bill Weber, vice president of marketing, product development, and sales for Integra. "This introduction further establishes the Integra Mozaik platform as an industry leading choice for collagen ceramic bone graft substitutes.”

Related Links:

Integra LifeSciences





Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.